Conference Information

Welcome Message

Greetings!

PULSUS Conferences takes honor and pleasure in welcoming the participants for the “2nd International Conference on Endocrinology Disorders, Diabetes complications and Hypertension” proposed on October 18-19, 2021 in Rome, Italy.

At PULSUS Group, it is our ethics to bring maximum exposure to our attendees, so we make sure the event is a blend that covers professionals such as Scholars, Researchers, Scientists, Experts in Endocrinology from academia & industry making the Endocrinology 2021 conference a perfect platform.

The invigorating theme of this conference is, “Exploring the revolution in Diabetes and Endocrinology” to promote the world’s famous scientific professionals in the specialization of Diabetes, Endocrinology Disorders, Diabetes complications, and Hypertension.

The conference will also include an in-depth understanding of the problems that arise from endocrinology, as well as potential concerns and solutions. ENDOCRINOLOGY 2021 offers an opportunity to network with world-renowned scientists, scholars, business leaders, and experts.

We soulfully welcome you to Rome and hoping that Endocrinology 2021 will inspire you and will result in new collaborations and friendships.

Best regards,
Organizing committee
Endocrinology 2021

About the conference

On behalf of the organising committee, PULSUS takes immense pleasure in inviting all the participants across the globe to attend the “2^nd International Conference on Endocrinology Disorders, Diabetes complications, and Hypertension”. This embraces proficient poster presentations, verbal speeches, and exhibitions, etc. providing insights into the importance and efficiency of diabetes in Healthcare. The conference takes place in Rome, Italy during October 18-19, 2021.

The milestone of the Endocrinology Congress 2021 will be the gathering of international experts and investigators to discuss the current situations and case studies, future innovations, and improvements on the topic of Endocrinology, Diabetes and Hypertension.

The conference will be organized under the theme “Exploring the revolution in Diabetes and Endocrinology”. Our goal is to deliver an impressive program that covers the whole spectrum of research & innovations in Diabetes and also promotes top-level research and focuses on the contemporary outstanding achievements within the field of Endocrinology.

Opportunities for Conference Attendees

Specialists & Educators:

• Speaker Presentations
• Poster Display
• Symposium hosting
• Workshop organizing

Students & Research Scholars:
• Poster Competition
• Young Researcher Forum
• Student Attendee
• Group Registrations

Business Delegates:

• Speaker Presentations
• Symposium hosting
• Book Launch event
• Networking opportunities
• Audience participation

Universities, Associations & Societies:

• Association Partnering
• Collaboration proposals
• Academic Partnering
• Group Participation

Companies:
• Exhibitor and Vendor Booths
• Sponsorships opportunities
• Product launch
• Workshop organizing
• Scientific Partnering
• Marketing and Networking with clients

Conference Dates: October 18-19, 2021.

Both individual and group registrations are available.

We soulfully invite all concerned people to come to join us at our event and make it successful by your participation.

For further details:

Contact:
Reynold Stuart
Program Manager | Endocrinology 2021
Contact no: +44 203 769 1778

Session and Tracks

Session 1 - Endocrinology:

Humans use hormones secreted by endocrine glands to maintain a constant blood glucose level throughout their lives, including glucose absorption at various levels. The flow of hormones into the blood stimulates by bringing the blood glucose level back to normal. In this session, we will delve deeper into endocrinology. Endocrinology is a branch of science and medicine that deals with the endocrine system, its diseases, and its specific discharges such as hormones, growth, and danger.

Related: Endocrinology conference | Endocrinology congress | Endocrinology gathering | Diabetes event | Diabetes meetings

Session 2 - Paediatric Endocrinology:

Paediatric Endocrinology is a field that deals with children's endocrinology. Children with type 1 and type 2 growth disorders, pubertal abnormalities, obesity, sex development differences, bone and mineral disturbances, hypoglycemia, and other disorders of the adrenal, parathyroid, thyroid, and pituitary glands are treated by pediatric endocrinologists.

Session 3 - Endocrine Disorder:

Due to the rising prevalence of endocrine disorders, the global market for endocrinology drugs is exploding. High cholesterol absorption, work stress, and weight gain are all factors that will wreak havoc on the endocrine system. During the period 2018-2022, the global endocrinology drug market grew at a 6.48 percent annual rate. Unless serious disorders are addressed, the growth of the pharmaceutical market will continue, leading to a life where we can't live without medicines. The session will cover all endocrine-related issues, with professionals sharing asset points for developing a better strategy to address these problems.

Session 4 - Cellular and Molecular Endocrinology:

It explains the cell science and structure of hormones as well as their endocrine glands. Topics like bone metabolism, thyroid-related diseases, and muscle metabolism are covered in cellular and molecular endocrinology research. The main goal of this discussion is to disseminate the most recent strategies and inventions in cellular and molecular endocrinology, with DNA technologies thrown in for good measure.

Session 5 - Diabetes Types and Complications:

Diabetes mellitus, also known as blood sugar, is caused by high blood glucose levels. Diabetes is a major health issue that is primarily affecting contagious populations. Damage to the eyes, kidneys, nerves, and stroke are all complications of diabetes. Diabetes is by far the most difficult medical problem of the twenty-first century. The complications of diabetes are the focus of this session.

Related: Diabetes conference | Endocrinology meetings | Endocrinology event | Diabetes gathering | Diabetes congress

Session 6- Pre-Diabetes:

Pre-Diabetes is a disorder in which blood sugar levels are elevated but not to the point where type 2 diabetes is diagnosed. Without treatment, it will most likely progress to type 2 diabetes within ten years. The majority of people with pre-diabetes have no signs or symptoms. It's not impossible to progress from pre-diabetes to type 2 diabetes. It is possible to restore a normal blood sugar level with lifestyle changes, weight loss, and medication.

Session 7 - Gestational Diabetes:

Gestational Diabetes is a major global issue that can lead to irreversible health problems for both the mother and the child. Regardless of its contingency, a large portion of the population still lacks epidemiological instructions to assist them in recognizing diabetes-related conditions. Diabetes and obesity are on the rise in many countries as a result of increased knowledge about gestational diabetes. Diabetes affects one out of every five women of reproductive age worldwide, and one out of every six children.

Session 8 - Genetic Diabetes:

Most people in the world still have no clear understanding of genetic Diabetes. It makes them treat pre-diabetic stages with disdain, which leads to a slew of complications. Some people are more susceptible to Diabetic diseases due to the genetic component that is provoking. There is another precedent that will bring the Diabetic conditions ahead. This session on Genetic Diabetes will cover the precautions and medications that must be followed to avoid developing genetic diabetes.

Session 9 - Thyroid Disorders:

Thyroid disease has become the most common problem in recent years, affecting 12 percent of the population. Hormones produced by the thyroid gland regulate your body's metabolism. When your thyroid produces too much hormone (hyperthyroidism) or not enough hormone (hypothyroidism), it can cause a variety of problems (hypothyroidism). This session raises awareness of thyroid-related problems and thyroid types.

Session 10 - Diabetes and Cancer:

Diabetes increases the risk of certain types of cancer, but not all. Diabetes and cancer have a complicated relationship. Diabetes increases the risk of liver and endometrial cancer by twofold. It raises the risk of breast and bladder cancer by 20 to 50% in women but lowers the risk in men. More questions about the relationship between diabetes and cancer incidence are addressed in this session.

Session 11 - Insulin Devices and Diabetes Medication:

Diabetes is primarily caused by the body's inability to produce insulin. Insulin is classified into several types based on how long it takes to act. Insulin is injected into diabetics who are unable to control their condition with oral medications. The focus is primarily on diabetes medication and new devices.

Session 12- Advance Tools and Technology for Diabetes:

The way of diagnosing Diabetes has been changed in the past as a result of advanced technological methods. Diabetes patients' lives have been improved as a result of innovations such as painless insulin delivery and the mass insulin production effect of medicines. Although the impact of previous leading technologies has been minimal, there will be some exciting changes in technology that will change how people receive medical care and learn how to manage it on their own. The focus of the discussion will be on the various diabetes innovation tools.

Session 13 - Types of Hypertensive Diseases

Hypertension is not caused by any medical disorder is known as Primary hypertension.
Secondary hypertension is a form of high blood pressure caused by a medical condition that affects the kidneys, arteries, heart, or endocrine system.
Resistant hypertension is a term for high blood pressure that is difficult to manage and takes several drugs to treat.
Malignant hypertension is a concept that describes elevated blood pressure that damages the organs.

Session 14 - Women Healthcare in Hypertension:

Hypertension is a huge risk factor for women's CVD. While women are more at risk than men for kicking the CVD hypertensive bucket, ladies do not consider CVD a major medical problem. Also, women in both high-salary countries (62% women versus 49% men) and in central and low-salary nations (36% women versus 22% men) showed higher rates of comparison and higher rates of male prescription antihypertension (BP <140/90 mm Hg) than female. The Women's Health Initiative (WHI) has shown that a greater risk of hypertension is associated with intermittent, premature birth.

Session 15 – Ketogenic Diet for Diabetes

A ketogenic diet is a very low-carb diet under which you ingest fewer than 30 grams of carbohydrates per day. This allows the body to get its calories from consuming body fat, which creates ketones, a form of energy. The diet reduces the body's appetite for hypoglycemic agents and has implications for people with type one and type two Diabetes. If you're thinking about starting the diet, you can talk to the doctor first and there might be steps that need to be taken.

Session 16 – Diagnosis of Endocrine Diseases:

Thyroid, parathyroid hormones, pancreas, and adrenal organs are all examples of endocrine organs, which contain hormones in the body. On the off chance that the thyroid endocrinology is producing more prohormones, a patient can experience symptoms such as tremors, sweating, palpitations, or difficulty sleeping. Initially, this is handled with a drug, or with pills such as radioactive iodine, which may damage the thyroid organ. Endocrine disruptors are compounds that can interact with the endocrine (or hormone) system in warm-blooded animals at particular concentrations.

Market Analysis

We aspire and expect the Endocrinology 2021 theme to inspire several people all around the world, research avenues, and look forward to discussing ideas, findings, and synergies, in this International Conference which is going to be held in Italy on October 18-19, 2021.

The demand for endocrine testing increases due to the maturing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency. The swelling diabetic, geriatric and obese population worldwide is expected to promote market growth. Furthermore, amplifying healthcare awareness among individuals coupled with increasing government support is expected to increase the diagnosis at an early, thereby contributing to the growth of the endocrine testing market.

According to the findings of the International Diabetes Conference, someone dies from diabetes or its complications every seven seconds. The majority of the deaths occur in people under the age of 60. The prevalence of diabetes has increased more rapidly in developing countries.

Diabetes is projected to grow to 9.9% of the global population by 2045. In 2017, a population of 424.9 million people with diabetes would rise to 48 percent or about 628.6 million people. Statistically, half of all deaths from hyperglycemia occur before the age of 70.

By the end of 2021, Italy's diabetes product market is estimated to be worth USD 1.42 billion. For the period 2016-2021, the market is expected to expand at a CAGR of nearly 6.29 percent.

In the present situation, North America is the most dominant region, with the United States responsible for more than one-third of the global market share. Europe follows North America. Europe is the world's second-largest market for diabetes products. This can be due to the region's rapidly aging population. Due to developments in the APAC and Latin American regions, this growth is expected to saturate in the future. In terms of market share, these economies are projected to surpass Europe.

3rd International Conference on
Endocrinology Disorders, Diabetes Complications and Hypertension

Quick Links

Theme: Exploring the revolution in Diabetes and Endocrinology

Conference Information

Welcome Message

About the conference

Session and Tracks

Market Analysis